[Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].
作者信息
Hommes O R
出版信息
Ned Tijdschr Geneeskd. 1976 Mar 6;120(10):424-30.
PMID:765862
Abstract
摘要
相似文献
1
[Treatment of multiple sclerosis using immunosuppression. Critical discussion of results].[使用免疫抑制治疗多发性硬化症。结果的批判性讨论]
Ned Tijdschr Geneeskd. 1976 Mar 6;120(10):424-30.
2
[Interaction of central nervous system local immunity and systemic immunity during multiple sclerosis].[多发性硬化症期间中枢神经系统局部免疫与全身免疫的相互作用]
Rev Neurol (Paris). 1972 Nov;127(5):497-504.
3
[IgG synthesis in the central nervous system in multiple sclerosis and other neurologic diseases. Measurement and validity].
Cas Lek Cesk. 1985 Sep 6;124(36):1131-6.
4
5
[Significance of increased immunoglobulin G levels in the cerebrospinal fluid of patients with multiple sclerosis].[多发性硬化症患者脑脊液中免疫球蛋白G水平升高的意义]
Ned Tijdschr Geneeskd. 1984 Sep 1;128(35):1666-8.
6
7
8
The future of multiple sclerosis treatment.多发性硬化症治疗的未来。
J Neurol Sci. 2009 Feb 1;277 Suppl 1:S55-61. doi: 10.1016/S0022-510X(09)70015-2.
9
Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.静脉注射甲泼尼龙治疗多发性硬化症的早期免疫抑制作用
Acta Neurol (Napoli). 1985 Jun-Aug;7(3-4):338-44.
10
The use of glatiramer acetate in the treatment of multiple sclerosis.醋酸格拉替雷在多发性硬化症治疗中的应用。
Adv Neurol. 2006;98:273-92.
引用本文的文献
1
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
J Neurol. 1977 Feb 17;214(3):173-81. doi: 10.1007/BF00316148.
Zotero 插件